A third dose of the unmodified COVID-19 mRNA vaccine CVnCoV enhances quality and quantity of immune responses

A third vaccine dose is often required to achieve potent, long-lasting immune responses. We investigated the effect of three 8-μg doses of CVnCoV, CureVac’s severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine candidate containing sequence-optimized unmodified mRNA encoding the spike...

Descripción completa

Detalles Bibliográficos
Autores principales: Lenart, Klara, Hellgren, Fredrika, Ols, Sebastian, Yan, Xianglei, Cagigi, Alberto, Cerveira, Rodrigo Arcoverde, Winge, Inga, Hanczak, Jakub, Mueller, Stefan O., Jasny, Edith, Schwendt, Kim, Rauch, Susanne, Petsch, Benjamin, Loré, Karin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9535876/
https://www.ncbi.nlm.nih.gov/pubmed/36217434
http://dx.doi.org/10.1016/j.omtm.2022.10.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9535876/
https://www.ncbi.nlm.nih.gov/pubmed/36217434
http://dx.doi.org/10.1016/j.omtm.2022.10.001

Ejemplares similares